<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" class="marks" width="621" height="444" viewBox="0 0 621 444"><rect width="621" height="444" fill="white"/><g fill="none" stroke-miterlimit="10" transform="translate(87,56)"><g class="mark-group role-frame root" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z"/><g><g class="mark-group role-scope concat_0_group" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0.5,0.5h200v200h-200Z" stroke="#ddd"/><g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="X-axis for a discrete scale with 3 values: Children, Pre-vaccination adults, Post-vaccination adults"><g transform="translate(0.5,200.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(37,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(100,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(162,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(37,7) rotate(270) translate(0,5)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">Children</text><text text-anchor="end" transform="translate(99.5,7) rotate(270) translate(0,5)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">Pre-vaccination adults</text><text text-anchor="end" transform="translate(162,7) rotate(270) translate(0,5)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">Post-vaccination adults</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,0)" x2="200" y2="0" stroke="#888" stroke-width="1" opacity="1"/></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="Y-axis titled 'neutralization titer' for a log scale with values from 30 to 10,100"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(0,200)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,190)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,182)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,176)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,171)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,166)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,162)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,159)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,135)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,121)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,111)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,103)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,97)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,92)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,87)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,83)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,79)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,56)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,42)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,32)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,24)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,18)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,13)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,8)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,4)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(-7,205)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">30</text><text text-anchor="end" transform="translate(-7,195.11247778394187)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,187.44311972424154)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,181.17679792009545)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,175.87869832555796)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,171.28927570403732)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,167.241118056249)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,163.61991764433697)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">100</text><text text-anchor="end" transform="translate(-7,139.79671556443242)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">200</text><text text-anchor="end" transform="translate(-7,125.861035700586)" font-family="sans-serif" font-size="17px" fill="#000" opacity="0">300</text><text text-anchor="end" transform="translate(-7,115.97351348452787)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,108.30415542482754)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,102.03783362068144)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,96.73973402614396)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,92.15031140462331)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,88.10215375683501)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,84.48095334492298)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">1,000</text><text text-anchor="end" transform="translate(-7,60.65775126501842)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">2,000</text><text text-anchor="end" transform="translate(-7,46.72207140117201)" font-family="sans-serif" font-size="17px" fill="#000" opacity="0">3,000</text><text text-anchor="end" transform="translate(-7,36.83454918511386)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,29.16519112541351)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,22.89886932126745)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,17.600769726729965)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,13.0113471052093)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,8.963189457421002)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1"/><text text-anchor="end" transform="translate(-7,5.341989045508928)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">10,000</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,200)" x2="0" y2="-200" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-title" pointer-events="none"><text text-anchor="middle" transform="translate(-62.99609375,100) rotate(-90) translate(0,-4)" font-family="sans-serif" font-size="17px" font-weight="bold" fill="#000" opacity="1">neutralization titer</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-symbol role-mark concat_0_layer_0_marks" role="graphics-object" aria-roledescription="symbol mark container"><path aria-label="expanded_group_detail: Children; neutralization titer: 89.1412196945; jitter: 0.412458980772; Cohort: SCH; serum: SCH23_y2009_s001" role="graphics-symbol" aria-roledescription="point" transform="translate(37.078196951883385,162.5706477430161)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 5152.45497835; jitter: −0.552168326697; Cohort: SCH; serum: SCH23_y2009_s002" role="graphics-symbol" aria-roledescription="point" transform="translate(30.554501386115305,23.132886543682595)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 52.1535859541; jitter: −0.289100653209; Cohort: SCH; serum: SCH23_y2009_s004" role="graphics-symbol" aria-roledescription="point" transform="translate(32.33360654076195,180.99375523976465)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 100.451134821; jitter: −0.63138189766; Cohort: SCH; serum: SCH23_y2009_s005" role="graphics-symbol" aria-roledescription="point" transform="translate(30.018786486029885,158.46521304245996)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 95.9279997752; jitter: −0.310963649079; Cohort: SCH; serum: SCH23_y2009_s006" role="graphics-symbol" aria-roledescription="point" transform="translate(32.18574888826642,160.04874086336164)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 2878.89287144; jitter: −0.526171573348; Cohort: SCH; serum: SCH23_y2009_s007" role="graphics-symbol" aria-roledescription="point" transform="translate(30.730315302261086,43.138322552123796)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 47.5521391561; jitter: 0.414598442187; Cohort: SCH; serum: SCH23_y2009_s009" role="graphics-symbol" aria-roledescription="point" transform="translate(37.09266595440258,184.16834484672353)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 46.8908237874; jitter: 1.87067568777; Cohort: SCH; serum: SCH23_y2010_s010" role="graphics-symbol" aria-roledescription="point" transform="translate(46.93999724687934,184.64968354540324)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 145.001522974; jitter: −1.08864962993; Cohort: SCH; serum: SCH23_y2010_s011" role="graphics-symbol" aria-roledescription="point" transform="translate(26.92632222103847,145.84906008500587)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 275.588762825; jitter: −2.14479254691; Cohort: SCH; serum: SCH23_y2011_s012" role="graphics-symbol" aria-roledescription="point" transform="translate(19.783714074904086,123.77807810419617)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 791.060052363; jitter: −0.938552698187; Cohort: SCH; serum: SCH23_y2011_s013" role="graphics-symbol" aria-roledescription="point" transform="translate(27.941415491222102,87.53655175557478)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 153.260109029; jitter: −2.35558903175; Cohort: SCH; serum: SCH23_y2012_s014" role="graphics-symbol" aria-roledescription="point" transform="translate(18.358114692868373,143.9452483310865)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 561.941195856; jitter: −0.968652624447; Cohort: SCH; serum: SCH23_y2012_s016" role="graphics-symbol" aria-roledescription="point" transform="translate(27.737852152354765,99.29015854100129)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 1224.99125852; jitter: 0.262739128873; Cohort: SCH; serum: SCH23_y2012_s017" role="graphics-symbol" aria-roledescription="point" transform="translate(36.06565384183559,72.50619982677308)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 68.8110753125; jitter: 0.650622548254; Cohort: SCH; serum: SCH23_y2012_s018" role="graphics-symbol" aria-roledescription="point" transform="translate(38.68887767497432,171.46746811288403)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 167.67169414; jitter: −1.22525894995; Cohort: SCH; serum: SCH23_y2013_s020" role="graphics-symbol" aria-roledescription="point" transform="translate(26.00244456556772,140.85640531010353)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 110.837955686; jitter: 1.29064876861; Cohort: SCH; serum: SCH23_y2013_s021" role="graphics-symbol" aria-roledescription="point" transform="translate(43.017322643676486,155.08331548554318)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 62.3199191762; jitter: −2.11660636077; Cohort: SCH; serum: SCH23_y2013_s023" role="graphics-symbol" aria-roledescription="point" transform="translate(19.974334945918432,174.8729335436247)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 108.05758347; jitter: −0.802892961573; Cohort: SCH; serum: SCH23_y2013_s024" role="graphics-symbol" aria-roledescription="point" transform="translate(28.858871191832964,155.95647593460376)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 243.535651098; jitter: −1.59412746296; Cohort: SCH; serum: SCH23_y2014_s025" role="graphics-symbol" aria-roledescription="point" transform="translate(23.507816988582928,128.02775808366346)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 63.1979502872; jitter: 1.21366116473; Cohort: SCH; serum: SCH23_y2014_s026" role="graphics-symbol" aria-roledescription="point" transform="translate(42.496661776868876,174.39207637072528)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 172.81673129; jitter: 1.69732411043; Cohort: SCH; serum: SCH23_y2014_s027" role="graphics-symbol" aria-roledescription="point" transform="translate(45.76763471094575,139.81762456887256)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 180.165601617; jitter: −0.159448663439; Cohort: SCH; serum: SCH23_y2014_s028" role="graphics-symbol" aria-roledescription="point" transform="translate(33.21043234094631,138.38631015795625)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 147.480526629; jitter: −0.0639097929439; Cohort: SCH; serum: SCH23_y2014_s029" role="graphics-symbol" aria-roledescription="point" transform="translate(33.85655390622198,145.2664298489609)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 710.026292027; jitter: 0.248686113703; Cohort: SCH; serum: SCH23_y2015_s031" role="graphics-symbol" aria-roledescription="point" transform="translate(35.970614449894924,91.25094085697019)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 372.142872574; jitter: 1.77855959446; Cohort: SCH; serum: SCH23_y2015_s032" role="graphics-symbol" aria-roledescription="point" transform="translate(46.31702364368251,113.45454262518943)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 317.181739775; jitter: −0.781345518982; Cohort: SCH; serum: SCH23_y2015_s033" role="graphics-symbol" aria-roledescription="point" transform="translate(29.00459478331766,118.94690772706593)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 512.735237075; jitter: −0.0605778465759; Cohort: SCH; serum: SCH23_y2015_s034" role="graphics-symbol" aria-roledescription="point" transform="translate(33.879087586927355,102.43970781880134)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 51.8573480617; jitter: 2.37522295266; Cohort: SCH; serum: SCH23_y2015_s035" role="graphics-symbol" aria-roledescription="point" transform="translate(50.352209123137115,181.18953484863977)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 91.1753204168; jitter: −1.8152112345; Cohort: SCH; serum: SCH23_y2016_s036" role="graphics-symbol" aria-roledescription="point" transform="translate(22.012645528212488,161.7951867075903)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 4508.64116156; jitter: 3.10572288099; Cohort: SCH; serum: SCH23_y2016_s037" role="graphics-symbol" aria-roledescription="point" transform="translate(55.292520377343244,27.720456290037742)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 147.561535011; jitter: 0.428396100952; Cohort: SCH; serum: SCH23_y2016_s038" role="graphics-symbol" aria-roledescription="point" transform="translate(37.18597839186908,145.24755642458013)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 118.050283707; jitter: −1.05584651657; Cohort: SCH; serum: SCH23_y2016_s039" role="graphics-symbol" aria-roledescription="point" transform="translate(27.14816699309095,152.9166071228676)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 1408.46999554; jitter: 2.0073731351; Cohort: SCH; serum: SCH23_y2016_s040" role="graphics-symbol" aria-roledescription="point" transform="translate(47.86447090016272,67.70922236273339)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 71.6906952395; jitter: −0.712377720512; Cohort: SCH; serum: SCH23_y2017_s041" role="graphics-symbol" aria-roledescription="point" transform="translate(29.4710183622199,170.0584425808891)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 1116.99188289; jitter: 1.5965451847; Cohort: SCH; serum: SCH23_y2017_s042" role="graphics-symbol" aria-roledescription="point" transform="translate(45.0860750808117,75.67832475406557)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 129.593841065; jitter: 0.604536091249; Cohort: SCH; serum: SCH23_y2018_s043" role="graphics-symbol" aria-roledescription="point" transform="translate(38.37719873651337,149.710107821887)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 72.0657743786; jitter: 3.45787826153; Cohort: SCH; serum: SCH23_y2018_s044" role="graphics-symbol" aria-roledescription="point" transform="translate(57.674118406664874,169.87909266949885)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 79.5139205225; jitter: 0.216256839908; Cohort: SCH; serum: SCH23_y2018_s045" role="graphics-symbol" aria-roledescription="point" transform="translate(35.751297924206625,166.49874226844724)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 74.6932357562; jitter: 0.724015865309; Cohort: SCH; serum: SCH23_y2018_s046" role="graphics-symbol" aria-roledescription="point" transform="translate(39.18523067402582,168.64830639739486)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 120.867321756; jitter: −0.237556698369; Cohort: SCH; serum: SCH23_y2018_s047" role="graphics-symbol" aria-roledescription="point" transform="translate(32.68219409061244,152.1060766343888)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 1358.74989971; jitter: −1.90037752755; Cohort: SCH; serum: SCH23_y2019_s048" role="graphics-symbol" aria-roledescription="point" transform="translate(21.4366728556064,68.94442922615379)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 86.5084584045; jitter: −0.588441260679; Cohort: SCH; serum: SCH23_y2019_s049" role="graphics-symbol" aria-roledescription="point" transform="translate(30.309190501027896,163.60103699778134)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 69.1059456661; jitter: 2.8598967411; Cohort: SCH; serum: SCH23_y2019_s050" role="graphics-symbol" aria-roledescription="point" transform="translate(53.63001830394929,171.32050153768233)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 296.618348016; jitter: −2.00030350053; Cohort: SCH; serum: SCH23_y2020_s051" role="graphics-symbol" aria-roledescription="point" transform="translate(20.760881675172953,121.25065604498242)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 88.1131806832; jitter: 1.54702227648; Cohort: SCH; serum: SCH23_y2020_s052" role="graphics-symbol" aria-roledescription="point" transform="translate(44.75115570391553,162.96932559409936)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 679.825202542; jitter: −0.813897826024; Cohort: SCH; serum: SCH23_y2020_s053" role="graphics-symbol" aria-roledescription="point" transform="translate(28.78444619384092,92.74486054290551)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 55.8403605632; jitter: −0.363266344179; Cohort: SCH; serum: SCH23_y2020_s054" role="graphics-symbol" aria-roledescription="point" transform="translate(31.83203004010856,178.6461739120554)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 87.8822767452; jitter: 0.860510835052; Cohort: SCH; serum: SCH23_y2020_s055" role="graphics-symbol" aria-roledescription="point" transform="translate(40.108334987961115,163.0595106958829)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 5542.5146478; jitter: 0.533715213712; Cohort: SCH; serum: SCH23_y2021_s056" role="graphics-symbol" aria-roledescription="point" transform="translate(37.89824293547308,20.624763529565392)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 42.2501791633; jitter: 0.73206957158; Cohort: SCH; serum: SCH23_y2021_s057" role="graphics-symbol" aria-roledescription="point" transform="translate(39.23969723067498,188.23145827760757)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 47.579142639; jitter: 0.0491867372447; Cohort: SCH; serum: SCH23_y2021_s059" role="graphics-symbol" aria-roledescription="point" transform="translate(34.62141648763807,184.148832876884)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 68.0074341887; jitter: 0.273124624146; Cohort: SCH; serum: SCH23_y2022_s062" role="graphics-symbol" aria-roledescription="point" transform="translate(36.135890096741335,171.87123152446685)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 44.6138736886; jitter: −1.43628475295; Cohort: SCH; serum: SCH23_y2022_s064" role="graphics-symbol" aria-roledescription="point" transform="translate(24.575294323551976,186.36050407370783)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 124.142981767; jitter: 0.116448978656; Cohort: SCH; serum: SCH23_y2022_s066" role="graphics-symbol" aria-roledescription="point" transform="translate(35.076305523684056,151.1870141949586)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; neutralization titer: 46.4931860609; jitter: 0.526529826388; Cohort: SCH; serum: SCH23_y2022_s067" role="graphics-symbol" aria-roledescription="point" transform="translate(37.849648748824414,184.94238329965572)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 275.198300767; jitter: 0.0319936839707; Cohort: PennVaccineCohort_d0; serum: PENN23_y1949_s012_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(97.00514127488233,123.82680848993361)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 773.226954618; jitter: −0.245126200841; Cohort: PennVaccineCohort_d28; serum: PENN23_y1949_s012_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(157.63100216464267,88.320222864819)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 92.6838538369; jitter: 1.70167297351; Cohort: PennVaccineCohort_d0; serum: PENN23_y1951_s014_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(108.29704571621072,161.2311802899281)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 818.349782547; jitter: 1.18251295737; Cohort: PennVaccineCohort_d28; serum: PENN23_y1951_s014_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(167.2860089987031,86.37087298316604)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 253.08537814; jitter: −1.02950438222; Cohort: PennVaccineCohort_d0; serum: PENN23_y1956_s042_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(89.82631669271075,126.70578059348254)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 244.343742837; jitter: 2.05926358699; Cohort: PennVaccineCohort_d28; serum: PENN23_y1956_s042_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(173.2154017812437,127.91390278210959)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 70.057093829; jitter: 1.71771598237; Cohort: PennVaccineCohort_d0; serum: PENN23_y1957_s008_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(108.40554327268276,170.85067699502088)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 100.071774875; jitter: 1.61209462138; Cohort: PennVaccineCohort_d28; serum: PENN23_y1957_s008_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(170.19123464902637,158.5952577445962)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 126.442899602; jitter: −0.829777933967; Cohort: PennVaccineCohort_d0; serum: PENN23_y1960_s003_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(91.17705032295109,150.55609667493036)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 491.918464876; jitter: 0.945384466029; Cohort: PennVaccineCohort_d28; serum: PENN23_y1960_s003_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(165.6823284108766,103.86421234640433)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 284.832381616; jitter: 0.100081800407; Cohort: PennVaccineCohort_d0; serum: PENN23_y1963_s051_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(97.46561563616166,122.64418641577484)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 666.801691048; jitter: −0.20782709948; Cohort: PennVaccineCohort_d28; serum: PENN23_y1963_s051_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(157.88325293576787,93.40967280952668)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 66.8795044847; jitter: 1.61189943084; Cohort: PennVaccineCohort_d0; serum: PENN23_y1964_s006_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(107.68991459131996,172.44604498265076)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 1764.76545045; jitter: 2.78035985654; Cohort: PennVaccineCohort_d28; serum: PENN23_y1964_s006_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(178.09211686042522,59.95840022739738)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 116.294275313; jitter: −0.591236532946; Cohort: PennVaccineCohort_d0; serum: PENN23_y1966_s057_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(92.79028630336153,153.43169877421698)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 144.673430521; jitter: −0.0340245748203; Cohort: PennVaccineCohort_d28; serum: PENN23_y1966_s057_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(159.05866519152883,145.92691573753214)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 49.5535125961; jitter: −2.75268198545; Cohort: PennVaccineCohort_d0; serum: PENN23_y1968_s033_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(78.1726075325457,182.75141026846114)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 194.977294169; jitter: 1.77256867572; Cohort: PennVaccineCohort_d28; serum: PENN23_y1968_s033_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(171.2765075503745,135.67088112665587)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 58.3890499357; jitter: −0.542380298676; Cohort: PennVaccineCohort_d0; serum: PENN23_y1968_s049_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(93.12069701887465,177.11220794249866)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 119.959630562; jitter: −0.209580452163; Cohort: PennVaccineCohort_d28; serum: PENN23_y1968_s049_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(157.87139515500928,152.36516013611876)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 127.537763309; jitter: 0.346609086491; Cohort: PennVaccineCohort_d0; serum: PENN23_y1971_s044_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(99.13285950393458,150.25977271621014)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 1760.13490015; jitter: −0.971433576436; Cohort: PennVaccineCohort_d28; serum: PENN23_y1971_s044_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(152.71904480156084,60.04870083684146)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 667.892009664; jitter: −1.5475368896; Cohort: PennVaccineCohort_d0; serum: PENN23_y1974_s034_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(86.322905224771,93.353519341626)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 1025.99519083; jitter: −0.288113158633; Cohort: PennVaccineCohort_d28; serum: PENN23_y1974_s034_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(157.34028488579202,78.59892385941374)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 49.6777413086; jitter: −0.313108339239; Cohort: PennVaccineCohort_d0; serum: PENN23_y1975_s030_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(94.67124452417066,182.66535481422275)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 60.1267912655; jitter: 2.26018450262; Cohort: PennVaccineCohort_d28; serum: PENN23_y1975_s030_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(174.57421349661803,176.10424510123434)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 106.233931853; jitter: −0.602498739175; Cohort: PennVaccineCohort_d0; serum: PENN23_y1976_s028_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(92.71412092397641,156.54147079951605)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 372.081344869; jitter: −0.727579131679; Cohort: PennVaccineCohort_d28; serum: PENN23_y1976_s028_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(154.36821246210062,113.46022554577306)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 966.033605354; jitter: 0.354707605191; Cohort: PennVaccineCohort_d0; serum: PENN23_y1977_s035_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(99.18762912337563,80.6686523666134)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 753.725640754; jitter: 0.783940167456; Cohort: PennVaccineCohort_d28; serum: PENN23_y1977_s035_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(164.59049382713562,89.19816643180366)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 151.499451543; jitter: −0.0834005100838; Cohort: PennVaccineCohort_d0; serum: PENN23_y1978_s039_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(96.22473978070981,144.34237315939959)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 398.933365821; jitter: 0.601300216791; Cohort: PennVaccineCohort_d28; serum: PENN23_y1978_s039_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(163.35531478227168,111.06528541431604)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 373.063033011; jitter: 0.466510558146; Cohort: PennVaccineCohort_d0; serum: PENN23_y1980_s016_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(99.94374334778381,113.36966520740947)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 1043.41155175; jitter: −2.07666466024; Cohort: PennVaccineCohort_d28; serum: PENN23_y1980_s016_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(145.2444573990307,78.02039306676151)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 201.301235561; jitter: −1.86423781842; Cohort: PennVaccineCohort_d0; serum: PENN23_y1981_s053_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(84.18108275191403,134.57382503398927)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 345.293164147; jitter: −0.676352103456; Cohort: PennVaccineCohort_d28; serum: PENN23_y1981_s053_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(154.71465666317465,116.02827826116628)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 85.2489092741; jitter: 0.820899822717; Cohort: PennVaccineCohort_d0; serum: PENN23_y1984_s041_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(102.3404489520517,164.1051317674373)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 423.177444984; jitter: 1.99338328751; Cohort: PennVaccineCohort_d28; serum: PENN23_y1984_s041_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(172.76985870540543,109.03757492659136)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 212.604255555; jitter: 0.427312126398; Cohort: PennVaccineCohort_d0; serum: PENN23_y1984_s047_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(99.6786475606391,132.69621253037087)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 266.851270083; jitter: 0.927354217365; Cohort: PennVaccineCohort_d28; serum: PENN23_y1984_s047_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(165.56039131418845,124.88540877341454)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 57.5617903374; jitter: 0.39680804108; Cohort: PennVaccineCohort_d0; serum: PENN23_y1985_s015_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(99.47235092712097,177.60264124481748)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 214.20639744; jitter: −0.174175916724; Cohort: PennVaccineCohort_d28; serum: PENN23_y1985_s015_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(158.11083313179356,132.43818120521865)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 120.087535025; jitter: −2.7213877924; Cohort: PennVaccineCohort_d0; serum: PENN23_y1986_s004_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(78.38424759996951,152.32853377038583)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 140.253822034; jitter: 4.17145802941; Cohort: PennVaccineCohort_d28; serum: PENN23_y1986_s004_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(187.5,146.9932400521781)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 154.63425845; jitter: 0.214705820528; Cohort: PennVaccineCohort_d0; serum: PENN23_y1987_s010_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(98.24080850702956,143.63845934229985)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 615.465499899; jitter: 2.77451401851; Cohort: PennVaccineCohort_d28; serum: PENN23_y1987_s010_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(178.05258193611465,96.16315314112389)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 73.489413839; jitter: −1.21268504005; Cohort: PennVaccineCohort_d0; serum: PENN23_y1987_s037_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(88.58748088954681,169.20674973461195)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 198.985888761; jitter: 0.379026522595; Cohort: PennVaccineCohort_d28; serum: PENN23_y1987_s037_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(161.85209597228723,134.97143196124946)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 189.084488998; jitter: 1.0346387889; Cohort: PennVaccineCohort_d0; serum: PENN23_y1988_s031_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(103.78594809467133,136.72565591791732)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 284.401839912; jitter: 0.610212941186; Cohort: PennVaccineCohort_d28; serum: PENN23_y1988_s031_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(163.41559080821904,122.6961775121938)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 65.4492922996; jitter: −3.22180011503; Cohort: PennVaccineCohort_d0; serum: PENN23_y1989_s026_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(75,173.1890088458573)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 423.744305026; jitter: 1.80959970393; Cohort: PennVaccineCohort_d28; serum: PENN23_y1989_s026_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(171.52694536471654,108.99156650939817)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 290.040570253; jitter: −1.73957822354; Cohort: PennVaccineCohort_d0; serum: PENN23_y1989_s052_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(85.02414539389034,122.0214111121121)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 835.299994031; jitter: 0.574235699363; Cohort: PennVaccineCohort_d28; serum: PENN23_y1989_s052_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(163.1722796650149,85.66625866427427)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 138.659367319; jitter: −0.976998310915; Cohort: PennVaccineCohort_d0; serum: PENN23_y1993_s020_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(90.18141095752358,147.38620384560744)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 536.190786912; jitter: −0.0216587813461; Cohort: PennVaccineCohort_d28; serum: PENN23_y1993_s020_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(159.14229404116875,100.90233984325528)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 51.5905340449; jitter: −1.12751751704; Cohort: PennVaccineCohort_d0; serum: PENN23_y1994_s005_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(89.16346188022932,181.36682828983925)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 245.550325754; jitter: 2.09000927575; Cohort: PennVaccineCohort_d28; serum: PENN23_y1994_s005_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(173.42333235903584,127.74460138647856)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 173.474458211; jitter: −0.830184409689; Cohort: PennVaccineCohort_d0; serum: PENN23_y1994_s024_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(91.17430136089655,139.68706480151786)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 218.316634075; jitter: 0.319557165341; Cohort: PennVaccineCohort_d28; serum: PENN23_y1994_s024_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(161.4499095742747,131.78493735418056)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 90.3797550541; jitter: −1.36580924719; Cohort: PennVaccineCohort_d0; serum: PENN23_y1995_s002_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(87.55191440347721,162.09640054654128)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 310.042635027; jitter: −0.238815668234; Cohort: PennVaccineCohort_d28; serum: PENN23_y1995_s002_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(157.67367978040795,119.7293354891006)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 58.7027745612; jitter: 1.44771675847; Cohort: PennVaccineCohort_d0; serum: PENN23_y1996_s043_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(106.57956060964204,176.92803418659778)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 155.372658089; jitter: 0.661539145078; Cohort: PennVaccineCohort_d28; serum: PENN23_y1996_s043_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(163.7627057262282,143.47473035248538)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 294.447480524; jitter: 0.574257579869; Cohort: PennVaccineCohort_d0; serum: PENN23_y1996_s056_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(100.6724276410844,121.50312273440551)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 983.115222482; jitter: −0.678510133213; Cohort: PennVaccineCohort_d28; serum: PENN23_y1996_s056_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(154.70006208447262,80.0662318281664)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 164.281445963; jitter: 0.509509347002; Cohort: PennVaccineCohort_d0; serum: PENN23_y1997_s027_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(100.23454063915413,141.55846571409313)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 2487.08612211; jitter: −0.74771320414; Cohort: PennVaccineCohort_d28; serum: PENN23_y1997_s027_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(154.23204737718453,48.16639133844607)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 306.77872946; jitter: 0.956427658602; Cohort: PennVaccineCohort_d0; serum: PENN23_y1997_s045_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(103.25701261882243,120.09307200292794)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 326.116022027; jitter: −2.21481447012; Cohort: PennVaccineCohort_d28; serum: PENN23_y1997_s045_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(144.31016153658456,117.99217848950126)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 85.0422825157; jitter: −0.320581437358; Cohort: PennVaccineCohort_d0; serum: PENN23_y1999_s046_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(94.6207045729513,164.18853814506042)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 204.140530343; jitter: −1.36087163863; Cohort: PennVaccineCohort_d28; serum: PENN23_y1999_s046_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(150.0853070462298,134.0924386872968)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 231.394475924; jitter: −2.11663813496; Cohort: PennVaccineCohort_d0; serum: PENN23_y1999_s048_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(82.47412005965586,129.7853996267465)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 1153.94903282; jitter: −1.61427873659; Cohort: PennVaccineCohort_d28; serum: PENN23_y1999_s048_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(148.37153557357044,74.55956805198183)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 594.512976609; jitter: −0.756531838903; Cohort: PennVaccineCohort_d0; serum: PENN23_y2001_s017_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(91.6724076717205,97.35359111230753)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 1850.34163234; jitter: −0.264135849879; Cohort: PennVaccineCohort_d28; serum: PENN23_y2001_s017_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(157.50244146335203,58.330913151112384)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; neutralization titer: 187.359631471; jitter: −2.57421433847; Cohort: PennVaccineCohort_d0; serum: PENN23_y2001_s025_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(79.37956962891147,137.04061955606036)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; neutralization titer: 435.690195927; jitter: 0.0287164259061; Cohort: PennVaccineCohort_d28; serum: PENN23_y2001_s025_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(159.48297744669932,108.03604954791433)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/></g><g class="mark-rule role-mark concat_0_layer_1_layer_0_marks" aria-hidden="true"><line transform="translate(37.5,188.23145827760757)" x2="0" y2="-17.861818970203046" stroke="black" stroke-width="2" opacity="0.8"/><line transform="translate(100,182.75141026846114)" x2="0" y2="-16.145271974354046" stroke="black" stroke-width="2" opacity="0.8"/><line transform="translate(162.5,176.10424510123434)" x2="0" y2="-43.99423777774604" stroke="black" stroke-width="2" opacity="0.8"/></g><g class="mark-rule role-mark concat_0_layer_1_layer_1_marks" aria-hidden="true"><line transform="translate(37.5,117.4893663556991)" x2="0" y2="-96.8646028261337" stroke="black" stroke-width="2" opacity="0.8"/><line transform="translate(100,128.2111087729603)" x2="0" y2="-47.5424564063469" stroke="black" stroke-width="2" opacity="0.8"/><line transform="translate(162.5,87.33172955678816)" x2="0" y2="-39.16533821834209" stroke="black" stroke-width="2" opacity="0.8"/></g><g class="mark-rect role-mark concat_0_layer_1_layer_2_marks" role="graphics-object" aria-roledescription="rect mark container"><path aria-label="expanded_group_detail: Children; geometric_mean: 71.0445078462; upper_box_geometric_mean: 330.922022975; Max of geometric_mean: 5542.5146478; Q3 of geometric_mean: 330.922022975; Median of geometric_mean: 119.458802731; Q1 of geometric_mean: 71.0445078462; Min of geometric_mean: 42.2501791633" role="graphics-symbol" aria-roledescription="box" d="M17.5,117.4893663556991h40v52.88027295170542h-40Z" fill="white" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; geometric_mean: 79.2658481773; upper_box_geometric_mean: 242.239927032; Max of geometric_mean: 966.033605354; Q3 of geometric_mean: 242.239927032; Median of geometric_mean: 138.659367319; Q1 of geometric_mean: 79.2658481773; Min of geometric_mean: 49.5535125961" role="graphics-symbol" aria-roledescription="box" d="M80,128.2111087729603h40v38.395029521146796h-40Z" fill="white" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; geometric_mean: 216.261515758; upper_box_geometric_mean: 795.788368582; Max of geometric_mean: 2487.08612211; Q3 of geometric_mean: 795.788368582; Median of geometric_mean: 398.933365821; Q1 of geometric_mean: 216.261515758; Min of geometric_mean: 60.1267912655" role="graphics-symbol" aria-roledescription="box" d="M142.5,87.33172955678816h40v44.77827776670014h-40Z" fill="white" stroke="black" stroke-width="2" opacity="0.8"/></g><g class="mark-rect role-mark concat_0_layer_1_layer_3_marks" aria-hidden="true"><path d="M17.5,152.00895261546583h40v1h-40Z" fill="white" stroke="black" stroke-width="2" opacity="0.8"/><path d="M80,146.88620384560744h40v1h-40Z" fill="white" stroke="black" stroke-width="2" opacity="0.8"/><path d="M142.5,110.56528541431604h40v1h-40Z" fill="white" stroke="black" stroke-width="2" opacity="0.8"/></g><g class="mark-group role-title"><g transform="translate(100,-48.658010954491075)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-text role-title-text" role="graphics-symbol" aria-roledescription="title" aria-label="Title text 'Per serum geometric mean titer across 2023-circulating strains'" pointer-events="none"><text text-anchor="middle" transform="translate(0,13)" font-family="sans-serif" font-size="17px" font-weight="bold" fill="#000" opacity="1"><tspan>Per serum geometric mean titer</tspan><tspan x="0" dy="19">across 2023-circulating strains</tspan></text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g></g><g class="mark-group role-scope concat_1_group" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(303,0)"><path class="background" aria-hidden="true" d="M0.5,0.5h200v200h-200Z" stroke="#ddd"/><g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="X-axis for a discrete scale with 3 values: Children, Pre-vaccination adults, Post-vaccination adults"><g transform="translate(0.5,200.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(37,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(100,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(162,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(37,7) rotate(270) translate(0,5)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">Children</text><text text-anchor="end" transform="translate(99.5,7) rotate(270) translate(0,5)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">Pre-vaccination adults</text><text text-anchor="end" transform="translate(162,7) rotate(270) translate(0,5)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">Post-vaccination adults</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,0)" x2="200" y2="0" stroke="#888" stroke-width="1" opacity="1"/></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="Y-axis titled 'coefficient of variation' for a linear scale with values from 0.0 to 0.4"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(0,200)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,150)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,100)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,50)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(-7,205)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">0.0</text><text text-anchor="end" transform="translate(-7,155)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">0.1</text><text text-anchor="end" transform="translate(-7,105)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">0.2</text><text text-anchor="end" transform="translate(-7,55.00000000000002)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">0.3</text><text text-anchor="end" transform="translate(-7,5)" font-family="sans-serif" font-size="17px" fill="#000" opacity="1">0.4</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,200)" x2="0" y2="-200" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-title" pointer-events="none"><text text-anchor="middle" transform="translate(-34.63232421875,100) rotate(-90) translate(0,-4)" font-family="sans-serif" font-size="17px" font-weight="bold" fill="#000" opacity="1">coefficient of variation</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-symbol role-mark concat_1_layer_0_marks" role="graphics-object" aria-roledescription="symbol mark container"><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0742271318245; jitter: 0.412458980772; Cohort: SCH; serum: SCH23_y2009_s001" role="graphics-symbol" aria-roledescription="point" transform="translate(37.078196951883385,162.8864340877718)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.034463730004; jitter: −0.552168326697; Cohort: SCH; serum: SCH23_y2009_s002" role="graphics-symbol" aria-roledescription="point" transform="translate(30.554501386115305,182.7681349980135)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0371876185022; jitter: −0.289100653209; Cohort: SCH; serum: SCH23_y2009_s004" role="graphics-symbol" aria-roledescription="point" transform="translate(32.33360654076195,181.40619074892294)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0506174544652; jitter: −0.63138189766; Cohort: SCH; serum: SCH23_y2009_s005" role="graphics-symbol" aria-roledescription="point" transform="translate(30.018786486029885,174.69127276739914)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0601238766071; jitter: −0.310963649079; Cohort: SCH; serum: SCH23_y2009_s006" role="graphics-symbol" aria-roledescription="point" transform="translate(32.18574888826642,169.93806169647462)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.373319906153; jitter: −0.526171573348; Cohort: SCH; serum: SCH23_y2009_s007" role="graphics-symbol" aria-roledescription="point" transform="translate(30.730315302261086,13.340046923698834)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0238175679364; jitter: 0.414598442187; Cohort: SCH; serum: SCH23_y2009_s009" role="graphics-symbol" aria-roledescription="point" transform="translate(37.09266595440258,188.0912160317751)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0240704596212; jitter: 1.87067568777; Cohort: SCH; serum: SCH23_y2010_s010" role="graphics-symbol" aria-roledescription="point" transform="translate(46.93999724687934,187.96477018939873)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0823316808951; jitter: −1.08864962993; Cohort: SCH; serum: SCH23_y2010_s011" role="graphics-symbol" aria-roledescription="point" transform="translate(26.92632222103847,158.83415955243842)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0431456030038; jitter: −2.14479254691; Cohort: SCH; serum: SCH23_y2011_s012" role="graphics-symbol" aria-roledescription="point" transform="translate(19.783714074904086,178.4271984981203)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.040608970411; jitter: −0.938552698187; Cohort: SCH; serum: SCH23_y2011_s013" role="graphics-symbol" aria-roledescription="point" transform="translate(27.941415491222102,179.6955147944943)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.116434365548; jitter: −2.35558903175; Cohort: SCH; serum: SCH23_y2012_s014" role="graphics-symbol" aria-roledescription="point" transform="translate(18.358114692868373,141.78281722623217)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0416179973268; jitter: −0.968652624447; Cohort: SCH; serum: SCH23_y2012_s016" role="graphics-symbol" aria-roledescription="point" transform="translate(27.737852152354765,179.19100133660731)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0603833208377; jitter: 0.262739128873; Cohort: SCH; serum: SCH23_y2012_s017" role="graphics-symbol" aria-roledescription="point" transform="translate(36.06565384183559,169.80833958116085)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0589161153302; jitter: 0.650622548254; Cohort: SCH; serum: SCH23_y2012_s018" role="graphics-symbol" aria-roledescription="point" transform="translate(38.68887767497432,170.54194233491046)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.147105553896; jitter: −1.22525894995; Cohort: SCH; serum: SCH23_y2013_s020" role="graphics-symbol" aria-roledescription="point" transform="translate(26.00244456556772,126.44722305180673)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0339230613141; jitter: 1.29064876861; Cohort: SCH; serum: SCH23_y2013_s021" role="graphics-symbol" aria-roledescription="point" transform="translate(43.017322643676486,183.03846934297223)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0638874246798; jitter: −2.11660636077; Cohort: SCH; serum: SCH23_y2013_s023" role="graphics-symbol" aria-roledescription="point" transform="translate(19.974334945918432,168.056287660082)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0407078029864; jitter: −0.802892961573; Cohort: SCH; serum: SCH23_y2013_s024" role="graphics-symbol" aria-roledescription="point" transform="translate(28.858871191832964,179.64609850680353)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0315489309371; jitter: −1.59412746296; Cohort: SCH; serum: SCH23_y2014_s025" role="graphics-symbol" aria-roledescription="point" transform="translate(23.507816988582928,184.2255345314538)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0809827178346; jitter: 1.21366116473; Cohort: SCH; serum: SCH23_y2014_s026" role="graphics-symbol" aria-roledescription="point" transform="translate(42.496661776868876,159.50864108269954)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0379795368123; jitter: 1.69732411043; Cohort: SCH; serum: SCH23_y2014_s027" role="graphics-symbol" aria-roledescription="point" transform="translate(45.76763471094575,181.01023159386241)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0254775519559; jitter: −0.159448663439; Cohort: SCH; serum: SCH23_y2014_s028" role="graphics-symbol" aria-roledescription="point" transform="translate(33.21043234094631,187.26122402207267)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0458968374704; jitter: −0.0639097929439; Cohort: SCH; serum: SCH23_y2014_s029" role="graphics-symbol" aria-roledescription="point" transform="translate(33.85655390622198,177.05158126480512)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0473767586056; jitter: 0.248686113703; Cohort: SCH; serum: SCH23_y2015_s031" role="graphics-symbol" aria-roledescription="point" transform="translate(35.970614449894924,176.3116206972235)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0469492887957; jitter: 1.77855959446; Cohort: SCH; serum: SCH23_y2015_s032" role="graphics-symbol" aria-roledescription="point" transform="translate(46.31702364368251,176.52535560213136)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0381003559033; jitter: −0.781345518982; Cohort: SCH; serum: SCH23_y2015_s033" role="graphics-symbol" aria-roledescription="point" transform="translate(29.00459478331766,180.9498220483261)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0385746361714; jitter: −0.0605778465759; Cohort: SCH; serum: SCH23_y2015_s034" role="graphics-symbol" aria-roledescription="point" transform="translate(33.879087586927355,180.71268191428928)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0297716774923; jitter: 2.37522295266; Cohort: SCH; serum: SCH23_y2015_s035" role="graphics-symbol" aria-roledescription="point" transform="translate(50.352209123137115,185.11416125386154)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0714182754604; jitter: −1.8152112345; Cohort: SCH; serum: SCH23_y2016_s036" role="graphics-symbol" aria-roledescription="point" transform="translate(22.012645528212488,164.29086226979243)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0170800630648; jitter: 3.10572288099; Cohort: SCH; serum: SCH23_y2016_s037" role="graphics-symbol" aria-roledescription="point" transform="translate(55.292520377343244,191.45996846762196)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0490442325391; jitter: 0.428396100952; Cohort: SCH; serum: SCH23_y2016_s038" role="graphics-symbol" aria-roledescription="point" transform="translate(37.18597839186908,175.47788373045537)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0554059940662; jitter: −1.05584651657; Cohort: SCH; serum: SCH23_y2016_s039" role="graphics-symbol" aria-roledescription="point" transform="translate(27.14816699309095,172.2970029669165)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0417546970515; jitter: 2.0073731351; Cohort: SCH; serum: SCH23_y2016_s040" role="graphics-symbol" aria-roledescription="point" transform="translate(47.86447090016272,179.1226514742698)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0360135011918; jitter: −0.712377720512; Cohort: SCH; serum: SCH23_y2017_s041" role="graphics-symbol" aria-roledescription="point" transform="translate(29.4710183622199,181.99324940408766)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0454091254281; jitter: 1.5965451847; Cohort: SCH; serum: SCH23_y2017_s042" role="graphics-symbol" aria-roledescription="point" transform="translate(45.0860750808117,177.29543728594516)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.139569332943; jitter: 0.604536091249; Cohort: SCH; serum: SCH23_y2018_s043" role="graphics-symbol" aria-roledescription="point" transform="translate(38.37719873651337,130.21533352874584)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0518583324677; jitter: 3.45787826153; Cohort: SCH; serum: SCH23_y2018_s044" role="graphics-symbol" aria-roledescription="point" transform="translate(57.674118406664874,174.070833766157)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0250377140021; jitter: 0.216256839908; Cohort: SCH; serum: SCH23_y2018_s045" role="graphics-symbol" aria-roledescription="point" transform="translate(35.751297924206625,187.4811429989311)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0325993739552; jitter: 0.724015865309; Cohort: SCH; serum: SCH23_y2018_s046" role="graphics-symbol" aria-roledescription="point" transform="translate(39.18523067402582,183.70031302242216)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0986288705244; jitter: −0.237556698369; Cohort: SCH; serum: SCH23_y2018_s047" role="graphics-symbol" aria-roledescription="point" transform="translate(32.68219409061244,150.68556473781646)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0325876330649; jitter: −1.90037752755; Cohort: SCH; serum: SCH23_y2019_s048" role="graphics-symbol" aria-roledescription="point" transform="translate(21.4366728556064,183.70618346755475)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0542355589342; jitter: −0.588441260679; Cohort: SCH; serum: SCH23_y2019_s049" role="graphics-symbol" aria-roledescription="point" transform="translate(30.309190501027896,172.88222053290224)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0616339156348; jitter: 2.8598967411; Cohort: SCH; serum: SCH23_y2019_s050" role="graphics-symbol" aria-roledescription="point" transform="translate(53.63001830394929,169.18304218262276)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0411019862301; jitter: −2.00030350053; Cohort: SCH; serum: SCH23_y2020_s051" role="graphics-symbol" aria-roledescription="point" transform="translate(20.760881675172953,179.4490068849609)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.060725662545; jitter: 1.54702227648; Cohort: SCH; serum: SCH23_y2020_s052" role="graphics-symbol" aria-roledescription="point" transform="translate(44.75115570391553,169.6371687274782)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0125950680801; jitter: −0.813897826024; Cohort: SCH; serum: SCH23_y2020_s053" role="graphics-symbol" aria-roledescription="point" transform="translate(28.78444619384092,193.70246595994132)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0586072214839; jitter: −0.363266344179; Cohort: SCH; serum: SCH23_y2020_s054" role="graphics-symbol" aria-roledescription="point" transform="translate(31.83203004010856,170.6963892580567)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0646692558451; jitter: 0.860510835052; Cohort: SCH; serum: SCH23_y2020_s055" role="graphics-symbol" aria-roledescription="point" transform="translate(40.108334987961115,167.6653720774479)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0196791841146; jitter: 0.533715213712; Cohort: SCH; serum: SCH23_y2021_s056" role="graphics-symbol" aria-roledescription="point" transform="translate(37.89824293547308,190.16040794271925)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.00505560499328; jitter: 0.73206957158; Cohort: SCH; serum: SCH23_y2021_s057" role="graphics-symbol" aria-roledescription="point" transform="translate(39.23969723067498,197.472197503359)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0232699937361; jitter: 0.0491867372447; Cohort: SCH; serum: SCH23_y2021_s059" role="graphics-symbol" aria-roledescription="point" transform="translate(34.62141648763807,188.36500313196433)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.108771312472; jitter: 0.273124624146; Cohort: SCH; serum: SCH23_y2022_s062" role="graphics-symbol" aria-roledescription="point" transform="translate(36.135890096741335,145.61434376401928)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.02182967471; jitter: −1.43628475295; Cohort: SCH; serum: SCH23_y2022_s064" role="graphics-symbol" aria-roledescription="point" transform="translate(24.575294323551976,189.08516264501415)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.0544100614279; jitter: 0.116448978656; Cohort: SCH; serum: SCH23_y2022_s066" role="graphics-symbol" aria-roledescription="point" transform="translate(35.076305523684056,172.79496928602657)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Children; coefficient of variation: 0.014485521841; jitter: 0.526529826388; Cohort: SCH; serum: SCH23_y2022_s067" role="graphics-symbol" aria-roledescription="point" transform="translate(37.849648748824414,192.7572390795201)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#345995" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0757210823385; jitter: 0.0319936839707; Cohort: PennVaccineCohort_d0; serum: PENN23_y1949_s012_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(97.00514127488233,162.13945883075527)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0438416498851; jitter: −0.245126200841; Cohort: PennVaccineCohort_d28; serum: PENN23_y1949_s012_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(157.63100216464267,178.07917505742694)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0803864953021; jitter: 1.70167297351; Cohort: PennVaccineCohort_d0; serum: PENN23_y1951_s014_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(108.29704571621072,159.80675234894784)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0878457448461; jitter: 1.18251295737; Cohort: PennVaccineCohort_d28; serum: PENN23_y1951_s014_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(167.2860089987031,156.07712757695157)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0361031710373; jitter: −1.02950438222; Cohort: PennVaccineCohort_d0; serum: PENN23_y1956_s042_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(89.82631669271075,181.94841448135588)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0222494553783; jitter: 2.05926358699; Cohort: PennVaccineCohort_d28; serum: PENN23_y1956_s042_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(173.2154017812437,188.87527231084786)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0521824602963; jitter: 1.71771598237; Cohort: PennVaccineCohort_d0; serum: PENN23_y1957_s008_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(108.40554327268276,173.90876985183073)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0410044189044; jitter: 1.61209462138; Cohort: PennVaccineCohort_d28; serum: PENN23_y1957_s008_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(170.19123464902637,179.49779054777628)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0519170716856; jitter: −0.829777933967; Cohort: PennVaccineCohort_d0; serum: PENN23_y1960_s003_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(91.17705032295109,174.04146415719302)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0607829133659; jitter: 0.945384466029; Cohort: PennVaccineCohort_d28; serum: PENN23_y1960_s003_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(165.6823284108766,169.60854331705764)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0757688291193; jitter: 0.100081800407; Cohort: PennVaccineCohort_d0; serum: PENN23_y1963_s051_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(97.46561563616166,162.1155854403259)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0352463128373; jitter: −0.20782709948; Cohort: PennVaccineCohort_d28; serum: PENN23_y1963_s051_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(157.88325293576787,182.37684358133606)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.06671213916; jitter: 1.61189943084; Cohort: PennVaccineCohort_d0; serum: PENN23_y1964_s006_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(107.68991459131996,166.64393041998832)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0840231451224; jitter: 2.78035985654; Cohort: PennVaccineCohort_d28; serum: PENN23_y1964_s006_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(178.09211686042522,157.98842743878092)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0656567190357; jitter: −0.591236532946; Cohort: PennVaccineCohort_d0; serum: PENN23_y1966_s057_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(92.79028630336153,167.17164048214164)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.051106441067; jitter: −0.0340245748203; Cohort: PennVaccineCohort_d28; serum: PENN23_y1966_s057_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(159.05866519152883,174.44677946650856)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0762191500545; jitter: −2.75268198545; Cohort: PennVaccineCohort_d0; serum: PENN23_y1968_s033_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(78.1726075325457,161.89042497272985)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0740197483226; jitter: 1.77256867572; Cohort: PennVaccineCohort_d28; serum: PENN23_y1968_s033_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(171.2765075503745,162.99012583871317)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0743984667512; jitter: −0.542380298676; Cohort: PennVaccineCohort_d0; serum: PENN23_y1968_s049_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(93.12069701887465,162.80076662440572)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0211689984896; jitter: −0.209580452163; Cohort: PennVaccineCohort_d28; serum: PENN23_y1968_s049_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(157.87139515500928,189.4155007552061)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0522912681383; jitter: 0.346609086491; Cohort: PennVaccineCohort_d0; serum: PENN23_y1971_s044_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(99.13285950393458,173.85436593085885)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0733044722051; jitter: −0.971433576436; Cohort: PennVaccineCohort_d28; serum: PENN23_y1971_s044_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(152.71904480156084,163.3477638974421)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.045752804344; jitter: −1.5475368896; Cohort: PennVaccineCohort_d0; serum: PENN23_y1974_s034_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(86.322905224771,177.12359782800524)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0435020992171; jitter: −0.288113158633; Cohort: PennVaccineCohort_d28; serum: PENN23_y1974_s034_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(157.34028488579202,178.2489503914478)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0465738909073; jitter: −0.313108339239; Cohort: PennVaccineCohort_d0; serum: PENN23_y1975_s030_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(94.67124452417066,176.7130545463599)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0594155792817; jitter: 2.26018450262; Cohort: PennVaccineCohort_d28; serum: PENN23_y1975_s030_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(174.57421349661803,170.29221035914352)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0732533601229; jitter: −0.602498739175; Cohort: PennVaccineCohort_d0; serum: PENN23_y1976_s028_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(92.71412092397641,163.37331993854613)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0099394772925; jitter: −0.727579131679; Cohort: PennVaccineCohort_d28; serum: PENN23_y1976_s028_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(154.36821246210062,195.0302613537508)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0330478834534; jitter: 0.354707605191; Cohort: PennVaccineCohort_d0; serum: PENN23_y1977_s035_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(99.18762912337563,183.47605827328067)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0325913042108; jitter: 0.783940167456; Cohort: PennVaccineCohort_d28; serum: PENN23_y1977_s035_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(164.59049382713562,183.7043478945918)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0533175272583; jitter: −0.0834005100838; Cohort: PennVaccineCohort_d0; serum: PENN23_y1978_s039_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(96.22473978070981,173.34123637085088)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0317121726087; jitter: 0.601300216791; Cohort: PennVaccineCohort_d28; serum: PENN23_y1978_s039_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(163.35531478227168,184.1439136956347)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0499159503922; jitter: 0.466510558146; Cohort: PennVaccineCohort_d0; serum: PENN23_y1980_s016_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(99.94374334778381,175.04202480388324)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0291258224533; jitter: −2.07666466024; Cohort: PennVaccineCohort_d28; serum: PENN23_y1980_s016_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(145.2444573990307,185.43708877332605)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0504368447953; jitter: −1.86423781842; Cohort: PennVaccineCohort_d0; serum: PENN23_y1981_s053_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(84.18108275191403,174.78157760233987)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0288926650663; jitter: −0.676352103456; Cohort: PennVaccineCohort_d28; serum: PENN23_y1981_s053_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(154.71465666317465,185.55366746685965)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.125191431507; jitter: 0.820899822717; Cohort: PennVaccineCohort_d0; serum: PENN23_y1984_s041_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(102.3404489520517,137.4042842465011)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0192667723096; jitter: 1.99338328751; Cohort: PennVaccineCohort_d28; serum: PENN23_y1984_s041_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(172.76985870540543,190.3666138451984)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0569863526258; jitter: 0.427312126398; Cohort: PennVaccineCohort_d0; serum: PENN23_y1984_s047_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(99.6786475606391,171.50682368709965)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0471694233793; jitter: 0.927354217365; Cohort: PennVaccineCohort_d28; serum: PENN23_y1984_s047_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(165.56039131418845,176.41528831033554)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0597549627085; jitter: 0.39680804108; Cohort: PennVaccineCohort_d0; serum: PENN23_y1985_s015_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(99.47235092712097,170.12251864575302)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.150578558958; jitter: −0.174175916724; Cohort: PennVaccineCohort_d28; serum: PENN23_y1985_s015_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(158.11083313179356,124.71072052118276)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0556422045175; jitter: −2.7213877924; Cohort: PennVaccineCohort_d0; serum: PENN23_y1986_s004_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(78.38424759996951,172.17889774124927)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0599508487093; jitter: 4.17145802941; Cohort: PennVaccineCohort_d28; serum: PENN23_y1986_s004_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(187.5,170.0245756453337)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.319039477304; jitter: 0.214705820528; Cohort: PennVaccineCohort_d0; serum: PENN23_y1987_s010_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(98.24080850702956,40.480261347803804)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.12565525693; jitter: 2.77451401851; Cohort: PennVaccineCohort_d28; serum: PENN23_y1987_s010_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(178.05258193611465,137.17237153508452)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0917548988308; jitter: −1.21268504005; Cohort: PennVaccineCohort_d0; serum: PENN23_y1987_s037_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(88.58748088954681,154.12255058462125)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0169116442372; jitter: 0.379026522595; Cohort: PennVaccineCohort_d28; serum: PENN23_y1987_s037_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(161.85209597228723,191.5441778814091)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.379945938064; jitter: 1.0346387889; Cohort: PennVaccineCohort_d0; serum: PENN23_y1988_s031_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(103.78594809467133,10.02703096779236)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.237956801168; jitter: 0.610212941186; Cohort: PennVaccineCohort_d28; serum: PENN23_y1988_s031_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(163.41559080821904,81.02159941624598)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0474667657113; jitter: −3.22180011503; Cohort: PennVaccineCohort_d0; serum: PENN23_y1989_s026_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(75,176.2666171443521)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.06776883732; jitter: 1.80959970393; Cohort: PennVaccineCohort_d28; serum: PENN23_y1989_s026_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(171.52694536471654,166.115581340009)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0452041032095; jitter: −1.73957822354; Cohort: PennVaccineCohort_d0; serum: PENN23_y1989_s052_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(85.02414539389034,177.3979483952328)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0333226682295; jitter: 0.574235699363; Cohort: PennVaccineCohort_d28; serum: PENN23_y1989_s052_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(163.1722796650149,183.3386658852561)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.106027738272; jitter: −0.976998310915; Cohort: PennVaccineCohort_d0; serum: PENN23_y1993_s020_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(90.18141095752358,146.9861308640593)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0538139833972; jitter: −0.0216587813461; Cohort: PennVaccineCohort_d28; serum: PENN23_y1993_s020_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(159.14229404116875,173.09300830142345)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0267555484351; jitter: −1.12751751704; Cohort: PennVaccineCohort_d0; serum: PENN23_y1994_s005_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(89.16346188022932,186.62222578243447)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0356436558976; jitter: 2.09000927575; Cohort: PennVaccineCohort_d28; serum: PENN23_y1994_s005_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(173.42333235903584,182.1781720512223)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0509173935178; jitter: −0.830184409689; Cohort: PennVaccineCohort_d0; serum: PENN23_y1994_s024_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(91.17430136089655,174.5413032410756)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0431607836473; jitter: 0.319557165341; Cohort: PennVaccineCohort_d28; serum: PENN23_y1994_s024_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(161.4499095742747,178.41960817633685)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.176467854156; jitter: −1.36580924719; Cohort: PennVaccineCohort_d0; serum: PENN23_y1995_s002_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(87.55191440347721,111.76607292195781)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.14784965976; jitter: −0.238815668234; Cohort: PennVaccineCohort_d28; serum: PENN23_y1995_s002_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(157.67367978040795,126.07517012015967)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.113909918308; jitter: 1.44771675847; Cohort: PennVaccineCohort_d0; serum: PENN23_y1996_s043_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(106.57956060964204,143.0450408461106)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0375909123992; jitter: 0.661539145078; Cohort: PennVaccineCohort_d28; serum: PENN23_y1996_s043_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(163.7627057262282,181.20454380039473)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.136335096296; jitter: 0.574257579869; Cohort: PennVaccineCohort_d0; serum: PENN23_y1996_s056_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(100.6724276410844,131.83245185224374)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0718986185819; jitter: −0.678510133213; Cohort: PennVaccineCohort_d28; serum: PENN23_y1996_s056_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(154.70006208447262,164.0506907090408)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.049804516236; jitter: 0.509509347002; Cohort: PennVaccineCohort_d0; serum: PENN23_y1997_s027_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(100.23454063915413,175.09774188201143)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0545547129456; jitter: −0.74771320414; Cohort: PennVaccineCohort_d28; serum: PENN23_y1997_s027_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(154.23204737718453,172.72264352720305)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0385840836213; jitter: 0.956427658602; Cohort: PennVaccineCohort_d0; serum: PENN23_y1997_s045_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(103.25701261882243,180.70795818933613)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0288468904225; jitter: −2.21481447012; Cohort: PennVaccineCohort_d28; serum: PENN23_y1997_s045_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(144.31016153658456,185.5765547887713)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.12516689013; jitter: −0.320581437358; Cohort: PennVaccineCohort_d0; serum: PENN23_y1999_s046_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(94.6207045729513,137.4165549348841)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.178468676895; jitter: −1.36087163863; Cohort: PennVaccineCohort_d28; serum: PENN23_y1999_s046_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(150.0853070462298,110.76566155266678)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.289245275356; jitter: −2.11663813496; Cohort: PennVaccineCohort_d0; serum: PENN23_y1999_s048_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(82.47412005965586,55.37736232199257)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.121421867456; jitter: −1.61427873659; Cohort: PennVaccineCohort_d28; serum: PENN23_y1999_s048_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(148.37153557357044,139.2890662721033)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0703389918533; jitter: −0.756531838903; Cohort: PennVaccineCohort_d0; serum: PENN23_y2001_s017_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(91.6724076717205,164.83050407334963)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0330187098292; jitter: −0.264135849879; Cohort: PennVaccineCohort_d28; serum: PENN23_y2001_s017_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(157.50244146335203,183.49064508540488)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; coefficient of variation: 0.0509959000745; jitter: −2.57421433847; Cohort: PennVaccineCohort_d0; serum: PENN23_y2001_s025_d0" role="graphics-symbol" aria-roledescription="point" transform="translate(79.37956962891147,174.50204996273268)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#03cea4" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; coefficient of variation: 0.0361925021667; jitter: 0.0287164259061; Cohort: PennVaccineCohort_d28; serum: PENN23_y2001_s025_d28" role="graphics-symbol" aria-roledescription="point" transform="translate(159.48297744669932,181.90374891665826)" d="M4.472,0A4.472,4.472,0,1,1,-4.472,0A4.472,4.472,0,1,1,4.472,0" fill="#515A47" stroke="black" stroke-width="2" opacity="0.8"/></g><g class="mark-rule role-mark concat_1_layer_1_layer_0_marks" aria-hidden="true"><line transform="translate(37.5,197.472197503359)" x2="0" y2="-13.770416869653701" stroke="black" stroke-width="2" opacity="0.8"/><line transform="translate(100,186.62222578243447)" x2="0" y2="-11.710424579322932" stroke="black" stroke-width="2" opacity="0.8"/><line transform="translate(162.5,195.0302613537508)" x2="0" y2="-11.432764863752453" stroke="black" stroke-width="2" opacity="0.8"/></g><g class="mark-rule role-mark concat_1_layer_1_layer_1_marks" aria-hidden="true"><line transform="translate(37.5,169.7655468677402)" x2="0" y2="-156.42549994404138" stroke="black" stroke-width="2" opacity="0.8"/><line transform="translate(100,156.96465146678455)" x2="0" y2="-146.93762049899217" stroke="black" stroke-width="2" opacity="0.8"/><line transform="translate(162.5,163.69922730324146)" x2="0" y2="-82.67762788699548" stroke="black" stroke-width="2" opacity="0.8"/></g><g class="mark-rect role-mark concat_1_layer_1_layer_2_marks" role="graphics-object" aria-roledescription="rect mark container"><path aria-label="expanded_group_detail: Children; geometric_CV: 0.0325964387326; upper_box_geometric_CV: 0.0604689062645; Max of geometric_CV: 0.373319906153; Q3 of geometric_CV: 0.0604689062645; Median of geometric_CV: 0.0442773642159; Q1 of geometric_CV: 0.0325964387326; Min of geometric_CV: 0.00505560499328" role="graphics-symbol" aria-roledescription="box" d="M17.5,169.7655468677402h40v13.936233765965113h-40Z" fill="white" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Pre-vaccination adults; geometric_CV: 0.0501763975938; upper_box_geometric_CV: 0.0860706970664; Max of geometric_CV: 0.379945938064; Q3 of geometric_CV: 0.0860706970664; Median of geometric_CV: 0.0597549627085; Q1 of geometric_CV: 0.0501763975938; Min of geometric_CV: 0.0267555484351" role="graphics-symbol" aria-roledescription="box" d="M80,156.96465146678455h40v17.947149736326992h-40Z" fill="white" stroke="black" stroke-width="2" opacity="0.8"/><path aria-label="expanded_group_detail: Post-vaccination adults; geometric_CV: 0.03280500702; upper_box_geometric_CV: 0.0726015453935; Max of geometric_CV: 0.237956801168; Q3 of geometric_CV: 0.0726015453935; Median of geometric_CV: 0.0438416498851; Q1 of geometric_CV: 0.03280500702; Min of geometric_CV: 0.0099394772925" role="graphics-symbol" aria-roledescription="box" d="M142.5,163.69922730324146h40v19.89826918675689h-40Z" fill="white" stroke="black" stroke-width="2" opacity="0.8"/></g><g class="mark-rect role-mark concat_1_layer_1_layer_3_marks" aria-hidden="true"><path d="M17.5,177.36131789203273h40v1h-40Z" fill="white" stroke="black" stroke-width="2" opacity="0.8"/><path d="M80,169.62251864575302h40v1h-40Z" fill="white" stroke="black" stroke-width="2" opacity="0.8"/><path d="M142.5,177.57917505742694h40v1h-40Z" fill="white" stroke="black" stroke-width="2" opacity="0.8"/></g><g class="mark-group role-title"><g transform="translate(100,-49)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-text role-title-text" role="graphics-symbol" aria-roledescription="title" aria-label="Title text 'Per serum GCV across 2023-circulating strains'" pointer-events="none"><text text-anchor="middle" transform="translate(0,13)" font-family="sans-serif" font-size="17px" font-weight="bold" fill="#000" opacity="1"><tspan>Per serum GCV</tspan><tspan x="0" dy="19">across 2023-circulating strains</tspan></text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g></g></g></svg>